Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program

BACKGROUND: If SGLT2 inhibitors protect the kidneys by reducing albuminuria as hypothesized, people with type 2 diabetes mellitus (T2DM) with higher albuminuria should benefit more. METHODS: We conducted a post-hoc analysis of data from the CANagliflozin cardioVascular Assessment Study (CANVAS) Prog...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Am Soc Nephrol
Главные авторы: Neuen, Brendon L., Ohkuma, Toshiaki, Neal, Bruce, Matthews, David R., de Zeeuw, Dick, Mahaffey, Kenneth W., Fulcher, Greg, Li, Qiang, Jardine, Meg, Oh, Richard, Heerspink, Hiddo L., Perkovic, Vlado
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Nephrology 2019
Предметы:
Clinical Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6830803/
https://ncbi.nlm.nih.gov/pubmed/31530577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2019010064
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы